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Abstract
Background: Calciphylaxis is a syndrome consisting of vascular calcification, thrombosis, and skin necrosis. The
syndrome develops often in chronic hemodialysis patients. However, there have been several case reports on
calciphylaxis in patients with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes)
syndrome, a systemic disease associated with plasma cell dyscrasia and upregulation of vascular endothelial growth
factor (VEGF).
Methods: In 76 POEMS patients and 86 age- and gender-matched disease controls, we studied abnormal small
vessel calcification by computed tomography (CT) of the soft tissues. Clinical and laboratory profiles were compared
between POEMS patients with and without calciphylaxis. Histological examination was performed in six autopsy
cases.
Results: Small vessel calcification on CT was found in 17 % of POEMS patients and in none of the controls
(P < 0.001). Autopsy confirmed calciphylaxis in 2 (33 %) patients. Among POEMS patients, higher disease activity,
including more severe neuropathy and ascites, higher serum levels of interleukin-6, and lower serum albumin levels,
was associated with the development of calciphylaxis. Serum levels of creatinine, calcium, and phosphate were not
related to the presence of calciphylaxis.
Conclusions: Calciphylaxis is often present in patients with POEMS syndrome. Upregulation of multiple
inflammatory cytokines such as VEGF and interleukin-6 may contribute to the development of calciphylaxis, by
entirely different mechanism from that in chronic dialysis. POEMS syndrome should be recognized as a potential
cause of calciphylaxis.
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Background
Calciphylaxis is a rare and life-threatening disease char-
acterized by calcification of the small- to medium-sized
arteries in the dermis and subcutis with intimal fibrosis,
resulting in progressive cutaneous necrosis accompanied
by severe pain [1–4]. End-stage renal disease and resulting
hyperparathyroidism have been considered as major causes
for calciphylaxis, which occurs in approximately 4 % of pa-
tients on chronic hemodialysis [4]. Calciphylaxis has also
been reported in non-uremic patients associated with the
use of warfarin, alcoholic liver cirrhosis, obesity, chronic in-
flammation, and prolonged corticosteroid administration
[5–10]. The treatment of calciphylaxis requires a multidis-
ciplinary approach involving optimal wound management,
antibiotic use, and correction of biochemical abnormalities
[4, 11, 12], but calciphylaxis is a fatal in 60–80 % of cases
due to bacterial infection [1, 2], and therefore early diagno-
sis and treatment are necessary.
Polyneuropathy, organomegaly, endocrinopathy, M-
protein, and skin changes (POEMS) syndrome is a rare
systemic disease characterized by a monoclonal plasma
cell proliferation and multiorgan involvement [13, 14].
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Markedly upregulated vascular endothelial growth fac-
tor (VEGF), presumably produced by plasma cells, has
been implicated in the pathogenesis of POEMS syn-
drome [13, 14]. As included in the disease acronym,
skin changes are one of the major features of the dis-
order. Typical skin changes include hyperpigmenta-
tion, acrocyanosis, hemangioma, telangiectasia,
hypertrichosis, and skin thickening [14]. To date, five
cases of POEMS syndrome have been reported to
present calciphylaxis [15–19]. We experienced a
POEMS syndrome patient who developed severe calci-
phylaxis, and this led us to systematically investigate
the prevalence of calciphylaxis and its risk factors in
POEMS syndrome.
Case report
A 62-year-old male with a six-year history of POEMS
syndrome was admitted to our hospital because of pain-
ful skin ulcers on both thighs. The diagnosis of POEMS
syndrome had been made based on polyneuropathy, M-
proteinemia (IgA λ type), elevated serum VEGF levels
(4810 pg/ml; normal <1000 pg/ml), edema, ascites/
pleural effusion, gynecomastia, and skin pigmentation.
Treatment with corticosteroids and thalidomide
followed by peripheral blood stem cell transplantation
(PBSCT) had resulted in clinical remission, but 2 years
later he had a relapse with skin ulcers. On admission, se-
vere skin ulcers were present on both thighs (Fig. 1a).
Thalidomide was switched to lenalidomide, but the
ulcers continued to increase in size. Laboratory examin-
ation showed slight leukocytosis and hypoalbuminemia
with a high serum C-reactive protein level. Serum cal-
cium and phosphorus concentrations and parathyroid
hormone levels were normal. Histology of hematoxylin
and eosin (HE) and von Kossa stained sections from the
ulcerative skin showed calcified vessels in the deep der-
mis (Fig. 1b). Computed tomography (CT) revealed ab-
normal calcification of the small vessels in the soft
tissues of the hip/thigh (Fig. 1c). Based on these findings,
a diagnosis of calciphylaxis was made. The ulcers en-
larged further over the next 8 weeks. He was treated
with continuous hemodiafiltration and high-dose corti-
costeroids because of septic shock. After transplantation




We reviewed the records of 76 patients with POEMS
syndrome (52 men), seen at Chiba University Hospital
between 1992 and 2013. Patient age ranged from 31 to
77 years (median, 56 years). All patients fulfilled the
diagnostic criteria of POEMS syndrome [13, 20]. One
patient with POEMS syndrome receiving chronic
hemodialysis was excluded, and the data from the
remaining 75 patients were analyzed.
To determine whether the vessel changes were caused
by calciphylaxis and not by aging, we reviewed the re-
cords of 86 age-matched patients (63 men) with various
neurological diseases who underwent CT evaluation dur-
ing the same period. The disorders included Parkinson-
ism (Parkinson disease, multiple system atrophy,
dementia with Lewy bodies, progressive supranuclear
palsy, and cortico-basal syndrome; n = 9), amyotrophic
lateral sclerosis (n = 5), other neurodegenerative diseases
Fig. 1 Findings in a patient with severe skin ulcers secondary to
calciphylaxis. a Calciphylaxis-induced skin ulcers on admission.
b Histology of biopsy specimen from the ulcer on the left thigh
stained with hematoxylin and eosin stain (B1) and von Kossa stain
(B2); Scale bars indicate 100 μm. Calcium deposits in the media of
small- and medium-sized arteries. c Plain computed tomography
showed multiple subcutaneous and intramuscular calcifications in
the soft tissue of the thighs
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(n = 7), multiple sclerosis (n = 4), immune-mediated neu-
ropathies (n = 13), and others (n = 42). The study proto-
col was approved by the Ethics Committee of the Chiba
University School of Medicine, Chiba, Japan.
Diagnosis of calciphylaxis
Diagnostic criteria for calciphylaxis have not been estab-
lished [11]. Therefore, we defined probable calciphylaxis
as (1) livedo reticularis that was followed by skin ulcer-
ation covered with necrotic tissue, or (2) calcification of
small- and medium-sized vessels on CT or histopath-
ology. CT images from the top of the chest to the upper
thigh were reviewed for the presence of calcification of
small- and medium-sized vessels (diameter <2 mm) in
the soft tissues of the hip/thigh. Calcification of small-
sized vessels appeared to indicate calciphylaxis [21], as
shown in the patient presented above.
Clinical and laboratory evaluation
We investigated the presence of ulcers and vessel calcifi-
cation on CT, and vascular risk factors such as diabetes,
hypertension, and hyperlipidemia. We then compared
clinical and laboratory data and treatment history be-
tween POEMS syndrome patients with probable calci-
phylaxis and those without it. The overall neuropathy
limitation scale (ONLS) was used to evaluate the severity
of neuropathy. The presence of pleural effusion/ascites
on CT was evaluated and history of events suggestive of
thrombosis, such as cerebral infarction, myocardial in-
farction, and pulmonary thromboembolism, was also
compared between POEMS patients with and without
probable calciphylaxis. Serum concentrations of VEGF,
tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6),
creatinine, calcium, phosphate, and albumin, and values
of platelet count, prothrombin time-international nor-
malized ratio (PT-INR), activated partial thromboplastin
time (APTT), fibrinogen degradation products (FDP),
and D-dimer measured around the time of CT (within 4
weeks) were recorded. Corrected serum concentration of
calcium ([Ca]) which was calculated by formula showed
below, were used for statistical analysis [22].
Corrected Ca½  mg=dlð Þ ¼ Measured Ca½  mg=dlð Þ
þ 4:0‐ Alb½  g=dlð Þf g
Ca½  : serum concentration of calcium;
Alb½  : serum concentration of albumin
Autopsy cases
During the study period, six of the 76 patients with POEMS
syndrome died. Autopsy reports were reviewed and abdom-
inal skin specimens from four patients were obtained and
investigated histopathologically by HE and von Kossa
staining. In the remaining two patients skin specimens were
not taken. The skin specimens from three autopsy cases of
plasma cell myeloma were compared as negative controls.
Statistical analysis
All statistical analyses were performed using SPSS statistic
software (IBM, version 20). The differences in gender,
prevalence of diabetes, hypertension, and hyperlipidemia
between the POEMS syndrome group and the neurological
disease control group were compared using Pearson’s chi-
squared test. The differences in age and serum concentra-
tion of creatinine were compared using the Mann–Whitney
U test and the differences in the prevalence of skin ulcers
and calcification seen on CT were compared using Fisher’s
exact test.
The differences in gender, ONLS score, presence of as-
cites, history of thrombosis, and treatments between the
patient groups were compared using Fisher’s exact test.
The differences in the presence of pleural effusion and
history of steroid therapy were compared using Pearson’s
chi-squared test and the differences in age, disease dur-
ation, and laboratory values were compared using the
Mann–Whitney U test.
Results
The frequency of calciphylaxis
The prevalence of calciphylaxis in POEMS syndrome pa-
tients and the neurological disease controls is shown in
Table 1. Skin ulcers consistent with calciphylaxis features
were present in 4 % of POEMS patients and in none of
the controls. Small vessel calcification on CT was ob-
served in 17 % of POEMS patients, and in none of the
controls (P = 0.00079), indicating that calciphylaxis was
not caused merely by aging, but was specifically present
in patients with POEMS syndrome (Fig. 2). There were
no significant differences in the prevalence of diabetes,
hypertension, or hyperlipidemia between the two groups.
Table 1 Vascular calcification and risk factors
POEMS syndrome Disease control P-value
(n = 75) (n = 86)
Gender; men:women 52:23 62:24 0.70
Age (years); mean (SD) 57 (11) 59 (14) 0.19
Calciphylaxis
Skin ulcer (%) 4 % 0 % 0.097
CTa 17 % 0 % 0.00079
Vascular risk factor
Diabetes 19 % 20 % 0.86
Hypertension 33 % 29 % 0.56
Hyperlipidemia 31 % 45 % 0.056
Disease controls include patients with various neurodegenerative or
inflammatory diseases (see text)
aSmall vessel calcification in the soft tissue of the hip/thigh
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Calcification of the large arteries such as the aorta (84 %
in POEMS syndrome patients versus 76 % in controls;
P = 0.19) and coronary arteries (31 % in POEMS syn-
drome patients versus 33 % in controls; P = 0.80) were
similarly present in both the groups, presumably reflect-
ing the effects of aging and atherosclerosis.
Histology in autopsy cases
Of the four autopsy cases which had obtained skin graft,
two patients with no history of dialysis showed calcifica-
tion in vessels with a diameter <0.6 mm in the abdominal
wall skin (Fig. 2d, e). No significant histopathological find-
ings were obtained from skin specimens of the three
plasma cell myeloma autopsy cases. The findings in the
POEMS syndrome cases were consistent with calciphy-
laxis, and small vascular calcification was also present on
CT of the soft tissue in the hip/thigh in these two
patients.
Factors associated with probable calciphylaxis in POEMS
syndrome
Clinical and laboratory findings were compared between
the 13 POEMS patients with and the 62 without calci-
phylaxis (Table 2). Compared with the group without
calciphylaxis, the calciphylaxis group included a higher
proportion of men, and the patients showed more severe
neuropathy (higher ONLS score) or ascites. In patients
with calciphylaxis, serum levels of IL-6 were significantly
higher compared with patients without calciphylaxis, but
serum VEGF levels were not significantly different be-
tween the two groups. Serum albumin concentration
was significantly lower in the calciphylaxis group com-
pared with the group without it.
There were no significant differences between the
groups for serum concentrations of creatinine, calcium, or
phosphate, which are known risk factors for calciphylaxis
in patients undergoing chronic hemodialysis. POEMS pa-
tients with and without calciphylaxis received similar
treatments. There were also no significant difference be-
tween the groups for hypertension (38 % in POEMS syn-
drome with calciphylaxis versus 32 % in POEMS
syndrome without calciphylaxis; P = 0.45), diabetes (15 %
in POEMS syndrome with calciphylaxis versus 19 % in
POEMS syndrome without calciphylaxis; P = 0.55) and
hyperlipidemia (38 % in POEMS syndrome with calciphy-
laxis versus 29 % in POEMS syndrome without calciphy-
laxis; P = 0.36) as a risk factor of atherosclerosis.
Discussion
Our results show that calciphylaxis is not rare, and prob-
able calciphylaxis, which fulfil both skin feature and ves-
sel calcification, occurs in 4 % of patients with POEMS
Fig. 2 Findings of calcification on computed tomography (CT). a Plain CT of a POEMS syndrome patient with calciphylaxis. b The same CT changes in a
chronic hemodialysis patient. c CT of a POEMS syndrome patient with no calcifications. d Ring-like calcification and occlusion of subcutaneous arterioles of
an autopsy case. Autopsy case skin samples were obtained from a grossly normal lesion. Medial thickening and intimal loose fibrous proliferation caused
arteriolar occlusion without any inflammation as seen on hematoxylin and eosin staining. e Calcification in the tunica media of arterioles as seen with von
Kossa staining; Scale bars indicate 100 μm
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syndrome, and calciphylaxis like calcification on CT
were seen 17 % of them. Because the resolution of CT is
not sufficiently high to detect very small vessel calcifica-
tion, the prevalence might be underestimated, because
two of the four autopsy cases had histological evidence
of calciphylaxis. Calcification of large vessels such as the
aorta and coronary arteries on CT, presumably caused by
aging and atherosclerosis, was similarly seen in POEMS
patients and disease controls, but calciphylaxis was specif-
ically observed in patients with POEMS syndrome, sug-
gesting that the pathophysiology of the syndrome is
directly related to the development of calciphylaxis.
Vascular calcifications are classified into arterial intima
calcification (AIC) and arterial media calcification (AMC),
or Mönckeberg arteriosclerosis [23, 24]. AIC represents
an advanced atherosclerosis associated with the develop-
ment of plaques and occlusive lesions. In contrast, AMC
is commonly associated with end-stage renal disease and
diabetes [23], and observed primarily in muscle-type con-
duit arteries, such as the femoral and tibial arteries. AIC
and AMC showed different patterns of vessel calcification
on X-ray [25], with discrete, irregular, and patchy
distribution of calcification typical of AIC, whereas uni-
form linear calcification suggests AMC.
Pathologically, the specific feature of calciphylaxis is
medial calcification in small-sized vessels with a diam-
eter <0.6 mm [4]. It is difficult to detect calcification of
small-sized vessels on CT, but previous reports have
shown that calciphylaxis patients often have abnormal
vascular calcification in muscle and connective tissue in
the lateral thighs, which can be detected by X-ray and
CT [16, 21]. Our study showed that the distribution of
calcification in POEMS syndrome resembles that for
AMC, and suggested that calcification of vessels <2 mm
in diameter detected on CT would represent calciphy-
laxis. In the case presented above, histopathology with
von Kossa staining identified small vessel calcification
consistent with calciphylaxis. Moreover, the two autopsy
cases showed small vessel calcification on both CT and
histology. Based on these findings, it is likely that vascu-
lar calcification in patients with POEMS syndrome indi-
cates calciphylaxis.
The precise mechanisms for AMC in POEMS syndrome
remain unknown. Previous studies have suggested that the
Table 2 Clinical and laboratory profiles of POEMS Syndrome Patients with and without calciphylaxis
Calciphylaxis P-value
Present (n = 13) Absent (n = 62)
Gender; men:women 12:1 40:22 0.043*
Age (years); mean (SD) 58 (11) 57 (11) 0.89
Disease duration 3.1 (2.0) 2.9 (3.3) 0.21
ONLS Leg score >5 46 % 18 % 0.042*
Pleural effusion 54 % 40 % 0.28
Ascites 54 % 13 % 0.0028*
Laboratory data
VEGF (pg/ml) 4100 (3100) 5100 (5500) (n = 57) 1.0
TNF-α (pg/ml) 18 (24) (n = 7) 8.9 (11) (n = 17) 0.22
IL-6 (pg/ml) 12 (4.4) (n = 5) 4.4 (2.1) (n = 13) 0.0013*
Cre (mg/dl) 0.86 (0.45) 0.94 (0.65) 0.83
Ca (mg/dl) 9.0 (0.48) 8.8 (0.42) 0.19
I-P (mg/dl) 4.1 (0.98) (n = 10) 4.0 (1.2) (n = 54) 0.88
Ca × I-P (mg2/dl2) 36 (8.4) (n = 10) 36 (9.9) (n = 54) 0.89
Albumin (g/dl) 3.1 (0.44) 3.7 (0.54) 0.00035*
Plt (103/μl) 260 (130) 310 (160) 0.21
Treatment
Corticosteroid 62 % 53 % 0.58
Thalidomide 15 % 8 % 0.35
Melphalan 8 % 19 % 0.29
PBSCT 15 % 3 % 0.14
Data are shown as mean (SD). ONLS, Overall Neuropathy Limitation Scale; VEGF, vascular endothelial growth factor; TNF-α: tumor necrosis factor-α;
IL-6: Interleukin-6;
Ca, serum concentration of calcium corrected by albumin concentration; I-P, serum concentration of phosphate; Plt, platelet count; PBSCT: peripheral blood stem
cell transplantation
*: p<0.05
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final common pathway that leads to AMC is nuclear fac-
tor κ-B (NFκB) activation [3]. NFκB is a key transcription
factor for numerous cellular functions, including produc-
tion of several growth factors, inflammatory mediators,
adhesion molecules, and cytokines, and it regulates the
balance between bone deposition and resorption. Activa-
tion of NFκB results in osseous mineral resorption and
extraosseous mineral deposition, causes osteoblastic trans-
formation in vascular smooth muscle cells, and finally
leads to AMC. Receptor activator of NFκB ligand
(RANKL) and its antagonist, osteoprotegerin (OPG), play
a critical role in bone remodeling [26].
Multiple proinflammatory cytokines such as interleukin-
1, TNF-α, and IL-6 are upregulated in POEMS syndrome
[14, 27, 28]. IL-6 may contribute to vascular calcification
by activating RANKL [29]. Our results show that, in
POEMS patients with calciphylaxis IL-6 levels were sig-
nificantly higher compared with POEMS patients without
calciphylaxis. We speculate that a upregulated cytokines
may induce vascular calcification in POEMS syndrome.
There are several limitations in this study. First, small
vessel calcification on CT is not a direct evidence for
calciphylaxis. However, we confirmed a relationship of
the CT findings and histological evidence of calciphy-
laxis in patients with biopsy or autopsy, and believe that
the CT findings reflect the presence of calciphylaxis.
Second, some medications may affect the finfings; for
example the use of statins that have anti-inflammatory
effects was not strictly checked in both the POEMS and
control groups. However, we think that this factor did
not largely affect the findings, and that calciphylaxis de-
velops by POEMS syndrome itself.
Conclusion
Comparison between POEMS syndrome patients with
and without calciphylaxis like calcification showed that
more severe neuropathy (higher ONLS score), more as-
cites, and lower serum concentrations of albumin were
associated with the presence of calciphylaxis like calcifi-
cation, suggesting that it is likely to develop with higher
disease activity. On the other hand, known risk factors
for calciphylaxis in hemodialysis, such as high serum cal-
cium and phosphate levels, had no relationship to calci-
fication in POEMS syndrome patients, indicating that
the mechanisms for calciphylaxis are different between
chronic hemodialysis and POEMS syndrome. We sug-
gest that POEMS syndrome should be recognized as a
cause of calciphylaxis, and that patients will benefit from
appropriate and timely management.
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